Advanced search
Start date
Betweenand

Nuclear ADAMTS-1 regulating normal and cancer cells

Grant number: 18/05566-6
Support Opportunities:Regular Research Grants
Start date: August 01, 2018
End date: January 31, 2021
Field of knowledge:Biological Sciences - Morphology - Cytology and Cell Biology
Principal Investigator:Vanessa Morais Freitas
Grantee:Vanessa Morais Freitas
Host Institution: Instituto de Ciências Biomédicas (ICB). Universidade de São Paulo (USP). São Paulo , SP, Brazil

Abstract

Cancer is the leading cause of death in economically developed countries and the leading cause of death in developing countries. The tumor occurs from a progressive succession of genetic alterations, each conferring a more potent growth type, leading to a progressive conduction of the normal cells in cells with malignant phenotype. The microenvironments in which the tumors develop may be regular aspects of the tumor such as angiogenesis, invasion and metastasis. This microenvironment consists of tumor stromal components, fibroblasts, endothelial cells, immune system cells, extracellular matrix proteins and proteoglycans, growth factors, and proteases that remodel these components. ADAMTS (a disintegrin and metalloproteinase with thrombospondin or adamalysin-thrombospondin motifs) are extracellular matrix metalloproteinases enzymes related to collagen processing, matrix proteoglycan cleavage, angiogenesis, von Willebrand factor cleavage, inflammation, organogenesis, and fertility. Although described as an extracellular protease, data published by our laboratory show that by both immunolocalization and immunoblott that ADAMTS-1 is present in the nucleus of three human mammary cell lines (MCF-10A, MCF-7 and MDA-MB- 231). In addition to our data, there are no other papers describing ADAMTS members in the nucleus, however literature data show that other matrix metalloproteases, MMP-2, MMP-3 and MMP inhibitor, TIMP-1 have already been observed in the nucleus of different cells. Thus, we intend to evaluate how ADAMTS-1 reaches the nucleus and if this protease presence in this cellular compartment is involved morphological changes or basic cell functions such as proliferation and migration. The info obtained here will help us to understand ADAMTS-1 function in the nuclei and have potential to fill gaps of our present knowledge on fundamental cell biology processes such as protein secretion, endocytosis and nucleocytoplasmic transport. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)

Scientific publications (5)
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
NORIEGA-GUERRA, HEYDI; FREITAS, VANESSA MORAIS. Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v. 19, n. 11, . (18/05566-6)
LIMA, MAIRA DE ASSIS; DA SILVA, SUELY VIEIRA; SERRANO-GARRIDO, ORLANDO; HUELSEMANN, MAREN; SANTOS-NERES, LUANA; CARLOS RODRIGUEZ-MANZANEQUE, JUAN; HODGSON, LOUIS; FREITAS, VANESSA M.. Metalloprotease ADAMTS-1 decreases cell migration and invasion modulating the spatiotemporal dynamics of Cdc42 activity. CELLULAR SIGNALLING, v. 77, . (15/19773-5, 18/19813-5, 18/05566-6)
LIMA, M. A.; SILVA, S. V.; FREITAS, V. M.. Progesterone and protease ADAMTS 1 regulating tumor cells migration and invasion.. MOLECULAR BIOLOGY OF THE CELL, v. 29, n. 26, p. 2-pg., . (15/19773-5, 18/05566-6)
NORIEGA-GUERRA, HEYDI; FREITAS, VANESSA MORAIS. Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v. 19, n. 11, p. 13-pg., . (18/05566-6)
LIMA, MAIRA A.; SILVA, V, SUELY; JAEGER, RUY G.; FREITAS, VANESSA M.. Progesterone decreases ovarian cancer cells migration and invasion. Steroids, v. 161, . (18/19813-5, 18/05566-6, 15/19773-5, 10/07699-1)